Does CYP1B1 hydroxylate estradiol to form catechol estrogens and do common variants alter metabolite patterns?

The metabolism of 17β-estradiol (E2) is a critical biological process mediated by the Cytochrome P450 (CYP) enzyme family, with CYP1B1 serving as a primary catalyst in extrahepatic tissues. Research confirms that CYP1B1 is fundamentally responsible for the hydroxylation of estradiol into catechol estrogens, and that common genetic variations in the CYP1B1 gene significantly alter the resulting metabolite profiles.

Clinical and Mechanistic Evidence

The CYP1B1 enzyme is uniquely characterized by its high regioselectivity for the C-4 position of the estrogen A-ring. While other enzymes like CYP1A1/2 primarily produce 2-hydroxyestradiol (2-OHE), CYP1B1 preferentially converts estradiol into 4-hydroxyestradiol (4-OHE).

• Catalytic Efficiency: Kinetic studies using recombinant human CYP1B1 demonstrate a high affinity (low Km) and high catalytic efficiency for 4-hydroxylation.
• Genotoxic Potential: This pathway is clinically significant because 4-OHE is a potent catechol estrogen that can further oxidize into reactive estrogen-3,4-quinones. These quinones are known to form depurinating DNA adducts, which are linked to the initiation of various cancers.

Impact of Genetic Variants

Common single nucleotide polymorphisms (SNPs) in the CYP1B1 gene—most notably the *2 (Arg48Gly), *3 (Ala432Val), and *4 (Asn453Ser) variants—directly influence enzyme function and metabolite patterns.

• Altered Ratios: The CYP1B13 (432Val) variant is frequently associated with increased 4-hydroxylase activity. Studies show that individuals carrying these variants exhibit higher ratios of 4-OHE to 2-OHE in both tissue and systemic circulation.
• Molecular Mechanism: These amino acid substitutions alter the enzyme's active site geometry or structural stability, changing the Vmax (maximum reaction rate) and Km (binding affinity) for estradiol. This results in a measurable shift in the balance of estrogen metabolites, potentially increasing the concentration of reactive, pro-carcinogenic intermediates.

Bottom line

The claim is strongly supported by biochemical and genetic evidence. CYP1B1 is the primary enzyme responsible for producing 4-hydroxy catechol estrogens from estradiol, and common variants like CYP1B13 significantly shift metabolite patterns toward these more reactive and potentially genotoxic forms.